| Authors: |
de Zawadzki A; Nordic Bioscience A/S, Fibrosis Biology and Biomarkers, Herlev, Denmark. Electronic address: anza@nordicbio.com., Leeming DJ; Nordic Bioscience A/S, Fibrosis Biology and Biomarkers, Herlev, Denmark., Sanyal AJ; Stravitz-Sanyal Institute for Liver Disease and Metabolic Health and Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University School of Medicine, Richmond, VA, USA., Anstee QM; Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK; Newcastle NIHR Biomedical Research Center, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle Upon Tyne, UK., Schattenberg JM; Department of Internal Medicine II, Saarland University Medical Centre, Homburg, Germany., Friedman SL; Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Schuppan D; Institute of Translational Immunology and Research Center for Immune Therapy, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Harvard Medical School, MA, USA., Karsdal MA; Nordic Bioscience A/S, Fibrosis Biology and Biomarkers, Herlev, Denmark. |
